Literature DB >> 15737103

Closure procedures for monotone bi-factorial dose-response designs.

M Hellmich1, W Lehmacher.   

Abstract

Two goals of multiple-dose factorial trials are (i) demonstrating improved effectiveness of a fixed combination over each of its components as well as (ii) identifying a safe and effective dose range. The authors address both goals though with focus on the second by closure procedures that guarantee strong control of the familywise error rate. Two different families of null hypotheses are investigated for bi-factorial dose-response designs that are monotone with respect to the matrix partial order. One is suitable to find the minimum effective dose(s) and the other one is large enough to identify the highest effective dose step(s). Likelihood ratio tests and appropriate multiple contrast tests are applied to an unbalanced clinical trial example taken from Hung (2000, Statistics in Medicine 19, 2079-2087). Full computer code written in the R language is available from the Internet.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737103     DOI: 10.1111/j.0006-341X.2005.030709.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  3 in total

1.  Expected loss functions as additional measures to assess performance of multiple testing procedures for combination drug dose finding.

Authors:  Julia N Soulakova; Allan R Sampson
Journal:  Pharm Stat       Date:  2012-03-06       Impact factor: 1.894

2.  On Identifying Minimum Efficacious Doses in Combination Drug Trials.

Authors:  Julia N Soulakova; Allan R Sampson
Journal:  Stat Biopharm Res       Date:  2009       Impact factor: 1.452

3.  Testing multiple dose combinations in clinical trials.

Authors:  Saswati Saha; Werner Brannath; Björn Bornkamp
Journal:  Stat Methods Med Res       Date:  2019-09-24       Impact factor: 3.021

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.